Fundamentals To A Very Successful Future, page-97

the whole world Medical Cannabis products, Canada, US, Europe are all growing significantly and all without "medical trials" proving their efficacy

proucts are helping people - you can see that from the  global growth including in Australia from the SAS growth

so trials are somewhat a theoretical outcome that should not be the only basis to establish commercial success from products

obviously trials and eventually a registered form drug would be a great outcome BUT IT SHOULD NOT BE THE ONLY BASIS  THAT MDC IS WORKING TO COMMERCIALISE ITS PRODUCTS

MESSAGE for the board - we are all watching revenues closely and especilly offshore initiatives in Europe, Canada and elsewhere / distribution agreements and so on. The buck stops with the board to maximise shareholder value, this cannot be purely an academic exercise.